Brief: Irlab Reports Positive Results From Second Part Of Phase I Study With IRL757
28/05/2025 06:05
May 28 (Reuters) - IRLAB Therapeutics AB IRLABa.ST: IRLAB REPORTS POSITIVE RESULTS FROM THE SECOND PART OF A PHASE I STUDY WITH IRL757 Source text: ID:nMFN4PC6nY Further company coverage: [IRLABa.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))